TScan Therapeutics Inc. (TCRX)
NASDAQ · Healthcare
TScan Therapeutics Inc. Cash on Hand 2020–2025
TScan Therapeutics Inc. annual cash on hand history from 2020 to 2025. Cash on hand refers to the total amount of cash and cash equivalents held by a company.
- TScan Therapeutics Inc. cash on hand as of December 31, 2025: 152.4M, a 14.71% decrease year-over-year.
- TScan Therapeutics Inc. cash on hand for 2025 were 152.4M, a 14.71% decrease from 2024.
- TScan Therapeutics Inc. cash on hand for 2024 were 178.7M, a 33.99% increase from 2023.
- TScan Therapeutics Inc. cash on hand for 2023 were 133.4M, a 11.11% increase from 2022.
- TScan Therapeutics Inc. cash on hand for 2022 were 120.0M.
Cash on Hand
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| TScan Therapeutics Inc. Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2025 | $152 |
| 2024 | $179 |
| 2023 | $133 |
| 2022 | $120 |
| 2021 | $161 |
| 2020 | $35 |
TScan Therapeutics Inc. Cash on Hand — FAQ
TScan Therapeutics Inc. (TCRX) cash on hand over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see TCRX's cash on hand history?
The chart and table above show TScan Therapeutics Inc.'s cash on hand by year and by quarter, including the growth rate.